Loss of heterozygosity (LOH) analysis of primary ovarian tumors using polymorphic markers in the 6q26 region showed 72% LOH in the center of PARK2, which was the highest among the markers tested. The gene discussed is PRKN; the disease is ovarian neoplasm.